Every asset move must meet FDA, EMA, and GxP compliance standards with full traceability.
Surplus builds up as operations scale or pivot across clinical and commercial phases.
Shutdowns or site transfers leave behind high-value tools without clear disposition paths.
Teams struggle to weigh resale opportunities against documentation gaps or obsolescence.
Involvement from QA, Validation, and Manufacturing complicates asset decisions.
For the Pharmaceutical & Biotech Industry
Track every action, relocation, and certification with GxP-compliant logs.
Maximize internal reuse with smart matching across departments and sites.
Attach calibration certs, decon protocols, chain-of-custody, and more.
Enable secure, role-specific access for QA, Facilities, and Ops.
List and find validated biotech tools within a trusted, domain-specific marketplace.
“Dynaprice ensures compliance and capital efficiency from molecule discovery to commercial scale-up — empowering life sciences organizations to act faster, smarter, and more traceably.”
Every transaction and asset change is logged for audit and regulatory compliance.
Easily categorize by unit operation, GMP relevance, or scale of use.
Batch-manage 100s of GxP-tagged assets during shutdowns or M&A transitions.
Align asset workflows with product scaling and site tech transfers.
Fermenters, TFF systems, bioreactors, chromatography skids
TOC analyzers, HPLC, spectrophotometers, mass specs
Biosafety cabinets, isolators, pass-throughs, HEPA systems
Shakers, hotplates, autoclaves, refrigerators
Fume hoods, UPS units, DI water systems
Pumps, probes, tubing, seals, controllers
Reused 40+ tools across two sites, saving $1.2M in capital expense and avoiding production delays.
Cleared 300+ GxP-classified assets in under 45 days using Dynaprice’s compliance-friendly batch tools.
Dynaprice helps you recover capital, manage compliance, and reduce surplus across every stage — discovery, development, and delivery.